Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes-Reference-Cited by-同舟云学术

Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes

Published:2021-04-20 Issue: Volume: Page:
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Dave Tarjani Vivek,Madhuri Bejjanki Kavya,Laghmisetty Srujana,Tripathy Devjyoti,Kaliki Swathi^ORCID,Rath Suryasnata,Mohapatra Samir,Desai Akruti,Kapoor Anasua Ganguly^ORCID

Funder

Hyderabad Eye Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/s41433-021-01527-9.pdf

Reference38 articles.

1. Nassiri N, Rootman J, Rootman DB, Goldberg RA. Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol. 2015;60:383–405.

2. Pires AM, Reinehr C, Boff F, Nazar FL. Intralesional bleomycin sclerotherapy of lymphangioma: partial response to treatment. Dermatol Surg. 2015;41:175–7.

3. Bothra N, Panda L, Sheth J, Tripathy D. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations. Eye 2018;32:152–5.

4. Hornblass A. The use of YAG-tipped contact laser in removing orbital lymphangiomas. Plast Reconstr Surg. 1989;83:397.

5. Lam SC, Yuen HKL. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what’s new? Curr Opin Ophthalmol. 2019;30:380–5.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sclerotherapy vs. surgical excision for lymphatic malformations of the head and neck: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-07-01

2. Two-Year Outcomes of Transcutaneous Non-Image Guided Bleomycin Sclerotherapy in Conjunctival Lymphatic Malformations: A Protocol-Based Management in 16 Eyes;Ophthalmic Plastic & Reconstructive Surgery;2022-07-13